Literature DB >> 2510814

Laboratory identification of the lupus anticoagulant.

D A Triplett1, J Brandt.   

Abstract

Mesh:

Substances:

Year:  1989        PMID: 2510814     DOI: 10.1111/j.1365-2141.1989.tb00242.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  7 in total

1.  Guidelines on testing for the lupus anticoagulant. Lupus Anticoagulant Working Party on behalf of the BCSH Haemostasis and Thrombosis Task Force.

Authors: 
Journal:  J Clin Pathol       Date:  1991-11       Impact factor: 3.411

2.  Methods for detecting lupus anticoagulants and their relation to thrombosis and miscarriage in patients with systemic lupus erythematosus.

Authors:  D Ferro; M Saliola; C Quintarelli; G Valesini; S Basili; A M Grandilli; M S Bonavita; F Violi
Journal:  J Clin Pathol       Date:  1992-04       Impact factor: 3.411

3.  Increased rate of factor V Leiden mutation in patients with cerebral venous thrombosis.

Authors:  M Weih; B Vetter; S Ziemer; S Mehraein; J M Valdueza; J Koscielny; A E Kulozik; K M Einhäupl
Journal:  J Neurol       Date:  1998-03       Impact factor: 4.849

4.  Anticardiolipin antibodies do not seem to be associated with APC resistance in vivo or in vitro.

Authors:  D A Tsakiris; M L Yasikoff; F Wolf; G A Marbet
Journal:  Ann Hematol       Date:  1995-10       Impact factor: 3.673

Review 5.  Antiphospholipid antibodies and the antiphospholipid syndrome.

Authors:  E N Harris; S S Pierangeli
Journal:  Springer Semin Immunopathol       Date:  1994

6.  Differences in functional activity of anticardiolipin antibodies from patients with syphilis and those with antiphospholipid syndrome.

Authors:  S S Pierangeli; G H Goldsmith; S Krnic; E N Harris
Journal:  Infect Immun       Date:  1994-09       Impact factor: 3.441

7.  Pregnancy outcome in women with antiphospholipid antibodies.

Authors:  A K al-Momen; S A Moghraby; M O el-Rab; A M Gader; S R al-Balla; A A al-Meshari; L al-Nuaim
Journal:  Clin Rheumatol       Date:  1993-09       Impact factor: 2.980

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.